The performance of the alarmin HMGB1 in pediatric diseases: From lab to clinic.

作者: Bo Li , Xin Peng , He Li , Fei Chen , Yuxia Chen

DOI: 10.1002/IID3.370

关键词:

摘要: Introduction The ubiquitously expressed nonhistone nuclear protein high-mobility group box 1 (HMGB1) has different functions related to posttranslational modifications and cellular localization. In the nucleus, HMGB1 modulates gene transcription, replication DNA repair as well determines chromosomal architecture. When post-transcriptional modified is released into extracellular space, it triggers several physiological pathological responses initiates innate immunity through interacting with its reciprocal receptors (i.e., TLR4/2 RAGE). effect of HMGB1-mediated inflammatory activation on systems received increasing attention. now considered be an alarmin participates in multiple inflammation-related diseases. addition, also affects occurrence progression tumors. However, most studies involving have been focused adults or mature animals. Due differences disease characteristics between children adults, necessary clarify role pediatric Methods results Through systematic database retrieval, this review aimed first elaborate under conditions then discuss clinical significance diseases according systems. Conclusions plays important a variety may used diagnostic biomarker therapeutic target for new strategies prevention treatment

参考文章(207)
Z H Aghai, J G Saslow, C Meniru, C Porter, R Eydelman, V Bhat, G Stahl, S Sannoh, K Pyon, C Hewitt, V Bhandari, High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy Journal of Perinatology. ,vol. 30, pp. 610- 615 ,(2010) , 10.1038/JP.2010.16
Ok-Hee Lee, Jayoung Kim, Jin-Moo Kim, Hyunji Lee, Eun Hee Kim, Soo-Kyung Bae, Youngsok Choi, Hyo Suk Nam, Ji Hoe Heo, Decreased expression of sirtuin 6 is associated with release of high mobility group box-1 after cerebral ischemia Biochemical and Biophysical Research Communications. ,vol. 438, pp. 388- 394 ,(2013) , 10.1016/J.BBRC.2013.07.085
Qingbing Meng, Jie Zhao, Hongbing Liu, Guoyou Zhou, Wensheng Zhang, Xingli Xu, Minqian Zheng, HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma Tumor Biology. ,vol. 35, pp. 12265- 12274 ,(2014) , 10.1007/S13277-014-2535-3
A. Bhandari, V. Bhandari, Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. ,vol. 123, pp. 1562- 1573 ,(2009) , 10.1542/PEDS.2008-1962
L Kuehl, B Salmond, L Tran, Concentrations of high-mobility-group proteins in the nucleus and cytoplasm of several rat tissues. Journal of Cell Biology. ,vol. 99, pp. 648- 654 ,(1984) , 10.1083/JCB.99.2.648
Paola Scaffidi, Tom Misteli, Marco E. Bianchi, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature. ,vol. 418, pp. 191- 195 ,(2002) , 10.1038/NATURE00858
F Kanakoudi-Tsakalidou, E Farmaki, V Tzimouli, A Taparkou, G Paterakis, M Trachana, P Pratsidou-Gertsi, P Nalbanti, F Papachristou, Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options? Lupus. ,vol. 23, pp. 305- 312 ,(2014) , 10.1177/0961203313519157
Jun Huang, Jiangdong Ni, Ke Liu, Yan Yu, Min Xie, Rui Kang, Philip Vernon, Lizhi Cao, Daolin Tang, HMGB1 Promotes Drug Resistance in Osteosarcoma Cancer Research. ,vol. 72, pp. 230- 238 ,(2012) , 10.1158/0008-5472.CAN-11-2001
Jessica E. Ellerman, Charles K. Brown, Michael de Vera, Herbert J. Zeh, Timothy Billiar, Anna Rubartelli, Michael T. Lotze, Masquerader: High Mobility Group Box-1 and Cancer Clinical Cancer Research. ,vol. 13, pp. 2836- 2848 ,(2007) , 10.1158/1078-0432.CCR-06-1953
Rui Kang, Kristen M Livesey, Herbert J Zeh, III, Michael T Loze, Daolin Tang, None, Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy. ,vol. 7, pp. 1256- 1258 ,(2011) , 10.4161/AUTO.7.10.16753